Acorah Software Products - Accounts Production 16.8.310 false true 31 January 2024 1 February 2023 false 1 February 2024 31 July 2025 31 July 2025 11799547 S Hospital true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11799547 2024-01-31 11799547 2025-07-31 11799547 2024-02-01 2025-07-31 11799547 frs-core:SharePremium 2024-01-31 11799547 frs-core:SharePremium 2025-07-31 11799547 frs-core:ShareCapital 2025-07-31 11799547 frs-core:RetainedEarningsAccumulatedLosses 2024-02-01 2025-07-31 11799547 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2024-01-31 11799547 frs-core:RetainedEarningsAccumulatedLosses 2025-07-31 11799547 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-07-31 11799547 frs-bus:FilletedAccounts 2024-02-01 2025-07-31 11799547 frs-bus:SmallEntities 2024-02-01 2025-07-31 11799547 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-07-31 11799547 frs-bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-07-31 11799547 frs-bus:OrdinaryShareClass1 2024-02-01 2025-07-31 11799547 frs-bus:OrdinaryShareClass1 2025-07-31 11799547 frs-bus:OrdinaryShareClass2 2024-02-01 2025-07-31 11799547 frs-bus:OrdinaryShareClass2 2025-07-31 11799547 1 2024-02-01 2025-07-31 11799547 frs-core:UnlistedNon-exchangeTraded 2025-07-31 11799547 frs-core:UnlistedNon-exchangeTraded 2024-01-31 11799547 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-01-31 11799547 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-07-31 11799547 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-01-31 11799547 frs-core:ImpairmentLossProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-07-31 11799547 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-07-31 11799547 frs-bus:Director1 2024-02-01 2025-07-31 11799547 frs-countries:EnglandWales 2024-02-01 2025-07-31 11799547 2023-01-31 11799547 2024-01-31 11799547 2023-02-01 2024-01-31 11799547 frs-core:SharePremium 2024-01-31 11799547 frs-core:ShareCapital 2024-01-31 11799547 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31 11799547 frs-bus:OrdinaryShareClass1 2023-02-01 2024-01-31 11799547 frs-bus:OrdinaryShareClass2 2023-02-01 2024-01-31
Registered number: 11799547
Oneragtime Exactcure Limited
Unaudited Financial Statements
For the Period 1 February 2024 to 31 July 2025
Oneragtime Exactcure Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—4

Page 1
Oneragtime Exactcure Limited
Balance Sheet
As At 31 July 2025
Balance Sheet
Registered number: 11799547

| 31 July 2025 | 31 January 2024
--- | --- | ---
| Notes | € | € | € | €
FIXED ASSETS
Investments | 4 |  | - |  | 699,892
|  |  | - |  | 699,892
CURRENT ASSETS
Debtors | 5 | - |  | 11,018 |
Cash at bank and in hand |  | 108 |  | 108 |
|  | 108 |  | 11,126 |
Creditors: Amounts Falling Due Within One Year | 6 | - |  | (11,018 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 108 |  | 108
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 108 |  | 700,000
NET ASSETS |  |  | 108 |  | 700,000
CAPITAL AND RESERVES
Called up share capital | 7 |  | 1,699 |  | 1,699
Share premium account |  |  | 698,301 |  | 698,301
Profit and Loss Account |  |  | (699,892 ) |  | -
SHAREHOLDERS' FUNDS |  |  | 108 |  | 700,000

Page 1
Page 2
Oneragtime Exactcure Limited
Balance Sheet (continued)
As At 31 July 2025
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

S Hospital Director
16/01/2026

The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Oneragtime Exactcure Limited
Notes to the Financial Statements
For the Period 1 February 2024 to 31 July 2025
Notes to the Financial Statements
1. General Information
Oneragtime Exactcure Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11799547 . The registered office is 2nd Floor, Heathmans House, 19 Heathmans Road, London, SW6 4TJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
2.2. Turnover
Turnover is recognised as management fees equal to the professional fees incurred during the year under review.
2.3. Foreign Currencies
The functional currency is Euros (EUR) and as such the accounts have been prepared in EUR.
2.4. Investment
Where possible, equity investments are valued in accordance with IPEVC (International Private Equity & Venture Capital) valuation guidelines, otherwise they are valued at cost less impairments.
As the investments are not listed, the valuation is based on the last issued share price and where investments are revalued upwards, the value does not reflect any performance fee due.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 1 (2024: 1)
1 1
4. Investments

| Unlisted
--- | ---
| €
Cost
As at 1 February 2024 | 699,892
As at 31 July 2025 | 699,892
Provision
As at 1 February 2024 | -
Impairment losses | 699,892
As at 31 July 2025 | 699,892
Net Book Value
As at 31 July 2025 | -
As at 1 February 2024 | 699,892

5. Debtors

| 31 July 2025 |  | 31 January 2024
--- | --- | --- | ---
| € |  | €
Due within one year
Other debtors | - |  | 11,018

6. Creditors: Amounts Falling Due Within One Year

| 31 July 2025 |  | 31 January 2024
--- | --- | --- | ---
| € |  | €
Other creditors | - |  | 11,018

Page 3
Page 4
Oneragtime Exactcure Limited
Notes to the Financial Statements (continued)
For the Period 1 February 2024 to 31 July 2025
7. Share Capital

| 31 July 2025 |  | 31 January 2024
--- | --- | --- | ---
Allotted, called up and fully paid | € |  | €
6,990 Ordinary Shares of € 0.10 each | 699 |  | 699
1,000 Ordinary A shares of € 1.00 each | 1,000 |  | 1,000
| 1,699 |  | 1,699

8. Reserves

| Share Premium | Profit and Loss Account
--- | --- | ---
| € | €
As at 1 February 2024 | 698,301 | -
Loss for the period and total comprehensive income | - | (699,892 )
As at 31 July 2025 | 698,301 | (699,892 )

9. Ultimate Controlling Party
The immediate and ultimate parent undertaking of the company is OneRagtime Venture Cloud a company incorporated in France with registered number SIREN 831125364 and trading address 60 Rue de Londres, Paris, 75008, France.
The ultimate controlling party is Mrs S C Hospital.
Page 4